Condition: Nodal Marginal Zone Lymphoma · Sponsor: International Extranodal Lymphoma Study Group (IELSG)
International retrospective observational cohort study aimed to describe a molecular classification for NMZL.
This description comes directly from the study's public registry record.
IELSG - Study Coordination Office · +41586667321 · ielsg@ior.usi.ch
Davide Rossi, MD · +41918118540 · davide.rossi@eoc.ch
Always discuss trial participation with your own doctor first.
| University of Miami | Miami, Florida, United States | Recruiting |
| Mayo Clinic | Rochester, Minnesota, United States | Recruiting |
| Weill Cornell Medical | New York, New York, United States | Recruiting |
| Ohio Health Riverside Methodist Hospital | Columbus, Ohio, United States | Recruiting |
| Hospital Italiano de Buenos Aires | Buenos Aires, Argentina | Recruiting |
| Hematology Center after Prof. Yeolyan | Yerevan, Armenia | Recruiting |
| Princess Margaret Cancer Centre | Toronto, Canada | Recruiting |
| University Hospital Centre Zagreb | Zagreb, Croatia | Recruiting |
| CHU Grenoble Alpes | Grenoble, France | Recruiting |
| Institut Universitaire du Cancer de Toulouse | Toulouse, France | Recruiting |
| Tata Memorial Hospital | Mumbai, India | Recruiting |
| AO SS Antonio e Biagio e C. Arrigo | Alessandria, AL, Italy | Recruiting |
+ 38 more locations — full list on the registry record.
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT05700149